GBC In­si­der Fo­cus In­dex

The GBC In­si­der in­dex has been pu­blicly lis­ted sin­ce Sep­tem­ber 2016. GBC has been ana­ly­zing the no­ti­fia­ble di­rec­tors‘ dealings of all com­pa­nies do­mic­i­led in the Ger­man-spea­king count­ries. In the case of an in­si­der purcha­se, the re­la­ted com­pa­ny is in­cluded in the in­dex – as­sum­ing that it is also con­vin­cing in the fur­ther ana­ly­sis – and an in­si­der sale leads to an exit from the in­dex. The GBC IFX ge­ne­ral­ly con­ta­ins bet­ween 30 and 100 shares and is ad­jus­ted weekly.

Sin­ce the launch, the GBC IFX has si­gni­fi­cant­ly out­per­for­med the DAX, MDAX, SDAX and the in­ter­na­tio­nal bench­marks MSCI World as well as the S&P 500.

„Much more at­ten­ti­on should be paid to in­si­der tran­sac­tions be­cau­se it re­al­ly pays off. Thanks to our sys­te­ma­tic in­vest­ment ap­proach, we have in­cluded top per­for­mers ear­ly on, such as Bio­test, Leo­ni, and Ra­tio­nal,“ says Ma­nu­el Hölz­le, Chief Ana­lyst of GBC AG. „We are the­r­e­fo­re very plea­sed to be able to of­fer in­ves­tors this at­trac­ti­ve in­vest­ment op­por­tu­ni­ty tog­e­ther with our part­ners GBC Ka­pi­tal und Dia­log Ver­mö­gens­ma­nage­ment.“